antoine yrondi
antoine yrondi
Psychiatry CHU Purpan, ToNIC (Inserm-UT3), TMBI (Univ. Toulouse)
Verified email at
Cited by
Cited by
Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?
W El-Hage, C Hingray, C Lemogne, A Yrondi, P Brunault, T Bienvenu, ...
Encephale, S73-S80, 2020
Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19): quels risques pour leur santé mentale?
W El-Hage, C Hingray, C Lemogne, A Yrondi, P Brunault, T Bienvenu, ...
L'encephale 46 (3), S73-S80, 2020
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
A Yrondi, M Sporer, P Peran, L Schmitt, C Arbus, A Sauvaget
Brain stimulation 11 (1), 29-51, 2018
Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and …
D Bennabi, T Charpeaud, A Yrondi, JB Genty, S Destouches, ...
BMC psychiatry 19, 1-12, 2019
Depression and sports-related concussion: a systematic review
A Yrondi, D Brauge, J LeMen, C Arbus, J Pariente
La Presse Médicale 46 (10), 890-902, 2017
Psychiatric disorders and hydroxychloroquine for coronavirus disease 2019 (COVID-19): a VigiBase study
P Garcia, A Revet, A Yrondi, V Rousseau, Y Degboe, F Montastruc
Drug Safety 43, 1315-1322, 2020
Structural–functional brain changes in depressed patients during and after electroconvulsive therapy
A Yrondi, P Peran, A Sauvaget, L Schmitt, C Arbus
Acta Neuropsychiatrica 30 (1), 17-28, 2018
Association between anhedonia and suicidal events in patients with mood disorders: A 3‐year prospective study
D Ducasse, J Dubois, I Jaussent, JM Azorin, B Etain, S Gard, C Henry, ...
Depression and anxiety 38 (1), 17-27, 2021
Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial
P Roullet, G Vaiva, E Véry, A Bourcier, A Yrondi, L Dupuch, P Lamy, ...
Neuropsychopharmacology 46 (9), 1643-1649, 2021
Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological …
D Bennabi, A Yrondi, T Charpeaud, JB Genty, S Destouches, ...
BMC psychiatry 19, 1-9, 2019
Grey Matter changes in treatment-resistant depression during electroconvulsive therapy
A Yrondi, F Nemmi, S Billoux, A Giron, M Sporer, S Taib, J Salles, D Pierre, ...
Journal of Affective Disorders 258, 42-49, 2019
Significant decrease in hippocampus and amygdala mean diffusivity in treatment-resistant depression patients who respond to electroconvulsive therapy
A Yrondi, F Nemmi, S Billoux, A Giron, M Sporer, S Taib, J Salles, D Pierre, ...
Frontiers in Psychiatry 10, 694, 2019
Neuroimaging biomarkers at baseline predict electroconvulsive therapy overall clinical response in depression: a systematic review
A Levy, S Taib, C Arbus, P Peran, A Sauvaget, L Schmitt, A Yrondi
The journal of ECT 35 (2), 77-83, 2019
Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study
N Hoertel, L Rotenberg, C Blanco, R Pascal de Raykeer, C Hanon, ...
European Archives of Psychiatry and Clinical Neuroscience 270, 673-688, 2020
Childhood maltreatment and clinical severity of treatment‐resistant depression in a French cohort of outpatients (FACE‐DR): One‐year follow‐up
A Yrondi, B Aouizerate, D Bennabi, R Richieri, T d'Amato, F Bellivier, ...
Depression and anxiety 37 (4), 365-374, 2020
Prevalence of metabolic syndrome and associated factors in a cohort of individuals with treatment-resistant depression: results from the FACE-DR study
O Godin, D Bennabi, A Yrondi, R Richieri, D Thierry, F Bellivier, ...
The Journal of clinical psychiatry 80 (6), 11800, 2019
Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: a real-world study using the WHO pharmacovigilance database
JB Quilichini, A Revet, P Garcia, R Bouquié, J Hamard, A Yrondi, ...
Journal of Affective Disorders 297, 189-193, 2022
Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine
B Coutens, A Yrondi, C Rampon, BP Guiard
Psychopharmacology 239 (9), 2735-2752, 2022
How does repetitive transcranial magnetic stimulation influence the brain in depressive disorders?: a review of neuroimaging magnetic resonance imaging studies
S Taib, C Arbus, A Sauvaget, M Sporer, L Schmitt, A Yrondi
The Journal of ECT 34 (2), 79-86, 2018
Cognitive impairments in treatment-resistant depression: Results from the French cohort of outpatients (FACE-DR)
A Vancappel, Y Dansou, O Godin, E Haffen, A Yrondi, F Stéphan, ...
Journal of Affective Disorders Reports 6, 100272, 2021
The system can't perform the operation now. Try again later.
Articles 1–20